Stryker Corporation (SYK)
Largest Insider Buys in Sector
SYK Stock Price History Chart
SYK Stock Performance
About Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and …
Insider Activity of Stryker Corporation
Over the last 12 months, insiders at Stryker Corporation have bought $0 and sold $200.35M worth of Stryker Corporation stock.
On average, over the past 5 years, insiders at Stryker Corporation have bought $29,617 and sold $114.05M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 53 shares for transaction amount of $10,173 was made by Doliveux Roch (director) on 2020‑07‑31.
List of Insider Buy and Sell Transactions, Stryker Corporation
| 2024-09-17 | Sale | VP, Chief HR Officer | 7,347 0.0019% | $366.98 | $2.7M | -1.16% | ||
| 2024-09-13 | Sale | VP, Chief HR Officer | 2,121 0.0006% | $370.00 | $784,770 | -2.77% | ||
| 2024-08-27 | Sale | Group President | 600 0.0002% | $355.00 | $213,000 | +0.49% | ||
| 2024-08-06 | Sale | 190,000 0.05% | $323.46 | $61.46M | +11.24% | |||
| 2024-08-02 | Sale | VP, Chief Financial Officer | 20,000 0.0053% | $333.00 | $6.66M | +8.19% | ||
| 2024-05-22 | Sale | VP, Chief Legal Officer | 2,007 0.0005% | $332.99 | $668,308 | +4.21% | ||
| 2024-05-15 | Sale | VP, Chief Financial Officer | 10,000 0.0026% | $327.65 | $3.28M | +4.95% | ||
| 2024-03-07 | Sale | VP, Chief Accounting Officer | 7,690 0.002% | $358.48 | $2.76M | -3.01% | ||
| 2024-02-09 | Sale | VP, Chief Financial Officer | 9,600 0.0027% | $342.81 | $3.29M | +2.04% | ||
| 2024-02-06 | Sale | 92,296 0.026% | $339.95 | $31.38M | +2.62% | |||
| 2024-02-05 | Sale | 201,146 0.0573% | $342.90 | $68.97M | +1.61% | |||
| 2024-02-02 | Sale | director | 3,273 0.0009% | $341.00 | $1.12M | +1.79% | ||
| 2023-12-01 | Sale | director | 500 0.0001% | $298.22 | $149,112 | +15.05% | ||
| 2023-11-28 | Sale | VP, Chief Accounting Officer | 573 0.0002% | $292.28 | $167,477 | +16.99% | ||
| 2023-11-17 | Sale | Chair and CEO | 56,483 0.0149% | $287.91 | $16.26M | +18.43% | ||
| 2023-11-16 | Sale | director | 500 0.0001% | $291.92 | $145,962 | +16.58% | ||
| 2023-11-15 | Sale | director | 500 0.0001% | $287.50 | $143,751 | +20.18% | ||
| 2023-11-14 | Sale | director | 750 0.0002% | $287.57 | $215,681 | +20.15% | ||
| 2023-09-06 | Sale | Group President | 5,000 0.0013% | $289.00 | $1.45M | +13.78% | ||
| 2023-08-10 | Sale | director | 750 0.0002% | $286.23 | $214,671 | +11.64% |
Insider Historical Profitability
| Doliveux Roch | director | 22070 0.0058% | $369.76 | 16 | 1 | +9.54% |
Institutional Investor Ownership
| The Vanguard Group | $11.26B | 8.26 | 31.46M | +0.99% | +$110.79M | 0.21 | |
| BlackRock | $9.39B | 6.89 | 26.24M | +5.29% | +$472.22M | 0.21 | |
| State Street | $5.15B | 3.77 | 14.35M | +0.61% | +$31.11M | 0.21 | |
| T. Rowe Price | $4.25B | 3.12 | 11.88M | -5.28% | -$236.89M | 0.52 | |
| Wellington Management Company | $3.88B | 2.85 | 10.84M | -10.9% | -$474.66M | 0.66 |